XRAY vs STAA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

XRAY

51.6
AI Score
VS
XRAY Wins

STAA

51.2
AI Score

Investment Advisor Scores

XRAY

52score
Recommendation
HOLD

STAA

51score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric XRAY STAA Winner
Revenue 113.12M 1.78B XRAY
Net Income 13.56M 27.00M XRAY
Gross Margin 78.1% 51.7% STAA
Net Margin 12.0% 1.5% STAA
Operating Income 18.12M 47.00M XRAY
ROE 5.8% 2.0% STAA
ROA 4.6% 0.5% STAA
Total Assets 294.44M 5.20B XRAY
Cash 173.08M 239.00M XRAY
Current Ratio 5.94 1.63 STAA

Relative Price Performance (Last 90 Days)

XRAY 1M: -8.3% · 3M: +3.2% STAA 1M: -10.8% · 3M: -21.6%

Current Technical Phase

XRAY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 36

RSI (14): 35.7 · Price: $10.46

STAA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.4%), weak momentum, RSI 42

RSI (14): 41.6 · Price: $22.66

Fundamentals Snapshot

Metric XRAY STAA
Market Cap
Forward P/E 6.9 22.1
Trailing P/E 292.8
Revenue (TTM)
Revenue Growth 0.0% 1.1%
Gross Margin 0.5% 0.8%
Operating Margin 0.1% 0.1%
EPS -2.68 0.08
Dividend Yield 0.03%

Frequently Asked Questions

Based on our detailed analysis, XRAY is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.